Home-based walking for quality of life after ovarian cancer

Evidence label: Positive randomized quality-of-life evidence; fatigue result uncertain · Clinical goal: improve physical quality of life and fatigue after ovarian cancer

Evidence at a glance

Population: 144 ovarian-cancer survivors; 113 completed the six-month assessment.
Intervention: a telephone-supported, home-based program built mainly around brisk walking, compared with attention control.
Result: physical quality of life improved by 3.7 points relative to control; the between-group fatigue difference did not reach statistical significance.

What was studied

The WALC trial randomized 74 women to exercise and 70 to attention control for six months. Participants in the exercise arm reported an average 166 minutes of activity per week. Outcomes included SF-36 physical and mental quality of life and the FACT-Fatigue scale.

What the evidence shows

The adjusted group difference in the SF-36 physical component was 3.7 points (95% CI 0.7 to 6.8; P=.02). Mental quality of life did not differ. Fatigue improved within the exercise group, but the between-group difference was 2.8 points (95% CI −0.2 to 5.7; P=.06), so a specific fatigue benefit remains uncertain.

This trial addressed survivorship and symptoms. It did not establish improved ovarian-cancer control or survival.

Limits and uncertainty

Twenty-one percent did not complete the six-month assessment, activity was largely self-reported and the comparison involved behavioral attention rather than blinded treatment. The clinical importance of a 3.7-point SF-36 difference may vary. The study received NIH funding.

Safety and practical context

Walking plans should account for anemia, neuropathy, falls, abdominal or pelvic symptoms, ostomies and treatment status. New calf swelling, chest pain, sudden breathlessness or severe abdominal symptoms need prompt clinical evaluation.

Questions for the care team

Is brisk walking appropriate with my current blood counts, neuropathy and balance?
What outcome should we track—walking tolerance, fatigue or everyday function?
Can an oncology exercise professional help me progress safely?

Sources

Literature searched: October 22, 2026 · Record appraised: October 22, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.